US FDA authorises emergency use of Remdesivir in coronavirus treatment

Washington D.C.: The US Food and Drug Administration has authorized an emergency use of Remdesivir drug in coronavirus treatment, FDA head Stephen Hahn announced on Friday.

"We authorized [a pharmaceutical company] Gilead's application for emergency use authorization for the use of Remdesivir in hospitalized patients," Hahn said at a White House event.

US President Donald Trump called Remdesivir use "a hot thing" and "really, a very promising situation." Gilead CEO Daniel O'Day announced that the company is donating 1.5 million vials of the medicine.

"We made a decision to donate about 1.5 million vials of Remdesivir. We will be working with the government to determine how best to distribute that. Gilead is fully committed to continue to expand the supply of the medicine," O'Day said.

FPJ Shorts

AI Solutions Provider Fractal Analytics, SaaS Firm Amagi Media Labs, & Cardiac Stent Maker Sahajanand Medical Receive SEBI Nod For IPOs

Telangana CM Revanth Reddy To Pave Way For Selling Products Made By Women, Amazon On Board, International Market Exposure On The Horizon

Financial Inclusion 2.0: SEBI To Free Small Investors From ZCZP Bond Grip In BSDA

Mumbai Shocker: Kalimata Idol Dressed As 'Mother Mary' In Chembur After Priest Claims 'Goddess Appeared In Dream'; Held Following Outrage

O'Day added that Remdesivir clinical trials started immediately when the manufacturer saw "COVID-19 circulating."